Search
Now showing items 11-20 of 141
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129
(MDPI, 2019)
Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set ...
Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis
(OXFORD UNIV PRESS, 2011)
Aims Loop diuretics are recommended to treat congestion in heart failure (HF), despite limited quality evidence. High-dose (HD) loop diuretics seem to worsen outcomes in chronic HF, though; data for acute HF are scarce, ...
Usefulness of admission matrix metalloproteinase 9 as a predictor of early mortality after cardiopulmonary resuscitation in cardiac arrest patients
(W B SAUNDERS CO-ELSEVIER INC, 2012)
Background: Matrix metalloproteinases (MMPs) have a central role in disease progression after ischemia-reperfusion injury. However, its prognostic significance in cardiac arrest (CA) patients having cardiopulmonary ...
Cancer antigen-125 levels predict long-term mortality in chronic obstructive pulmonary disease
(INFORMA HEALTHCARE, 2015)
Background: Cancer antigen-125 (CA-125) might be a useful biomarker to predict long-term mortality in patients with recent exacerbation of chronic obstructive pulmonary disease (COPD). Methods: A total of 87 consecutive ...
Cost of heart failure management in Turkey: results of a Delphi Panel
(TURKISH SOC CARDIOLOGY, 2016)
Objective: To analyze health-related cost of heart failure (HF) and to evaluate health-related source utilization aiming to provide data on the economic burden of HF in actual clinical practice in Turkey. Methods: The study ...
Association between oxidative stress index and post-CPR early mortality in cardiac arrest patients: A prospective observational study
(TURKISH SOC CARDIOLOGY, 2015)
Objective: Cardiopulmonary resuscitation (CPR) is a series of lifesaving actions that improve the chance of survival following cardiac arrest (CA). Many clinical and laboratory parameters, such as the presence of asystole, ...
MicroRNA-221/222 expression in atherosclerotic coronary artery plaque versus internal mammarian artery and in peripheral blood samples
(TAYLOR & FRANCIS LTD, 2018)
Background: Atherosclerosis is a disease of the arterial wall with predilection to some sites on others. MicroRNAs (miRNAs) are a class of the non-coding RNAs regulating the target gene expression at post-transcriptional ...
Cardiac cachexia and gastrointestinal system
(ELSEVIER IRELAND LTD, 2011)
…
Mean Platelet Volume as a Predictor of Heart Failure-Related Hospitalizations in Stable Heart Failure Outpatients with Sinus Rhythm
(TAIWAN SOC CARDIOLOGY, 2017)
Background: In this study, we investigated the relationship between the mean platelet volume (MPV) with mortality and heart failure (HF)-related hospitalization in stable chronic HF outpatients with reduced ejection fraction ...
CA-125 and heart failure
(ELSEVIER IRELAND LTD, 2011)
…